MARKET

ABBV

ABBV

Abbvie Inc
NYSE
198.47
+5.13
+2.65%
After Hours: 198.34 -0.13 -0.07% 19:49 05/02 EDT
OPEN
195.17
PREV CLOSE
193.34
HIGH
198.98
LOW
194.63
VOLUME
6.43M
TURNOVER
--
52 WEEK HIGH
216.66
52 WEEK LOW
148.20
MARKET CAP
351.09B
P/E (TTM)
83.03
1D
5D
1M
3M
1Y
5Y
1D
Benzinga Bulls And Bears: Lilly, Microsoft, Starbucks — And Markets Fully Recover Tariff Chaos Losses
Benzinga · 2h ago
Trump Says Drug Tariffs Are Coming. Big Pharma Execs Can't Figure Out How Much to Worry.
Barron‘s · 20h ago
Ardelyx: Revenue Misses And Losses Widen Amid XPHOZAH Uncertainty
Seeking Alpha · 23h ago
Validea Detailed Fundamental Analysis - ABBV
NASDAQ · 1d ago
3 Biotech Giants Gaining From U.S. Sales and Policy Shifts
NASDAQ · 1d ago
Shareholders of Cerevel Therapeutics Holdings, Inc. Should Contact Levi & Korsinsky Before June 3, 2025 to Discuss Your Rights - ABBV
PR Newswire · 1d ago
BOTOX® Cosmetic (onabotulinumtoxinA) Continues its Mission of Empowering Entrepreneurs Through "The Confidence Project"
PR Newswire · 1d ago
AbbVie shares snap seven-session gaining streak
Seeking Alpha · 1d ago
More
About ABBV
More
AbbVie Inc. is a global, diversified research-based biopharmaceutical company. The Company is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. Its product portfolio includes Immunology, Oncology, Aesthetics, Neuroscience, Eye Care and Other Key Products. Its Immunology products include rheumatology, dermatology and gastroenterology. Its Oncology products include Imbruvica, Venclexta/Venclyxto, Elahere, and Epkinly. The Company’s Aesthetics portfolio consists of facial injectables, plastics and regenerative medicine, body contouring, and skincare products. Its Neuroscience products include Botox Therapeutic, Vraylar, Duopa and Duodopa, Ubrelvy, and Qulipta. Its Eye Care products include Ozurdex, Lumigan/Ganfort, Alphagan/Combigan, Restasis, and Other eye care. Its Other key products include Mavyret/Maviret, Creon, and Linzess/Constella. Its Venclexta is a B-cell lymphoma 2 (BCL-2) inhibitor used to treat blood cancers.
Recently
Symbol
Price
%Change

Webull offers AbbVie Inc stock information, including NYSE: ABBV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ABBV stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ABBV stock methods without spending real money on the virtual paper trading platform.